Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: A new hypothesis with supporting data

Chest

Volumn 118, Issue 5, 2000, Pages 1480-1485

  Lieberman, J ^a  

^a NONE   (United States)

Author keywords

Antitrypsin; Augmentation therapy; Emphysema; Infections; 1 proteinase inhibitor

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; AGED; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; DETERIORATION; DISEASE SEVERITY; FEMALE; HUMAN; LUNG EMPHYSEMA; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHENOTYPE; PRIORITY JOURNAL;

EID: 0033739182     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.118.5.1480     Document Type: Article

References (15)

1. 1-antitrypsin deficiency in patients with pulmonary emphysema
2. 1-Antitrypsin Pi-types in 965 COPD patients
3. 1-antitrypsin deficiency in obstructive lung disease
4. 1-antitrypsin deficiency
5. 1-antitrypsin deficiency associated with emphysema
6. 1-antitrypsin deficiency
7. 1-antitrypsin
8. 1-antitrypsin deficiency?
9. 1-antitrypsin augmentation therapy
10. 1-Antitrypsin is an effector of immunological stasis
11. Antibiotic actions of trypsin inhibitors
12. Protease inhibitor use among a community sample of people with HIV disease
13. Aerosolized prolastin suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection
14. 1-antitrypsin deficiency in the pathogenesis of immune disorders